Emi Sei

The University of Texas MD Anderson Cancer Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

24h-index5.1kcitations155works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(131), Prostate Cancer Treatment and Research(77), Genetic factors in colorectal cancer(46), Single-cell and spatial transcriptomics(35), Cancer Immunotherapy and Biomarkers(19)

Publications155 total

Delineating the copy-number substructure of metastatic tumors with CopyKit
Molecular Cell·2026
Coalescing single-cell genomes and transcriptomes to decode breast cancer progression
Cell·2025Open Access
Figure S1 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Table S6 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S8 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S18 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S17 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Table S7 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S4 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S2 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S24 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Table S1 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S5 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S14 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Table S4 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S16 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S9 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S3 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Table S3 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
Figure S7 from Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy
2025Open Access
page 1 of 8Next →

Frequent Co-authors

Nicholas E. Navin(45), Shanshan Bai(24), Tod D. Casasent(15), Min Hu(13), Aislyn Schalck(12), Ruli Gao(10), Tapsi Kumar(10), Amado J. Zurita(10), Funda Meric‐Bernstam(9), Alastair M. Thompson(9), Naveen Ramesh(9), Christopher J. Logothetis(9), Alexander Davis(8), Bora Lim(8), Paul G. Corn(8), Ana M. Aparicio(8), Kaile Wang(7), Hui Chen(7), Jianzhuo Li(7), Darlan Conterno Minussi(6)